Characterisation of the Novel HLA‐A*03:535 Allele by Next Generation Sequencing and Oxford Nanopore Sequencing
HLA · 2026-05 · 107 (5)
DOI: 10.1111/tan.70761 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 22.05.2026. Verfasst von Jarret Merschman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Alleles, Exons, High-Throughput Nucleotide Sequencing, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
The novel HLA‐A*03:535 allele is characterised by a single nucleotide substitution in exon 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Jarret Merschman, Manish J Gandhi
Zitieren
APA
Merschman, J., Barnes, R., Kreuter, J., Wakefield, L., & Gandhi, M. J. (2026). Characterisation of the Novel HLA‐A*03:535 Allele by Next Generation Sequencing and Oxford Nanopore Sequencing. HLA, 107(5). https://doi.org/10.1111/tan.70761
Vancouver
Merschman J, Barnes R, Kreuter J, Wakefield L, Gandhi MJ. Characterisation of the Novel HLA‐A*03:535 Allele by Next Generation Sequencing and Oxford Nanopore Sequencing. HLA. 2026;107(5). doi:10.1111/tan.70761
BibTeX
@article{Merschman2026,
author = {Merschman, Jarret and Barnes, Rachel and Kreuter, Justin and Wakefield, Laurie and Gandhi, Manish J},
title = {Characterisation of the Novel HLA‐A*03:535 Allele by Next Generation Sequencing and Oxford Nanopore Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {5},
doi = {10.1111/tan.70761}
}
EUVIMED